Covid-19 and Unaccounted Collateral Damage

Dr Metzler and collaborators carried out a retrospective search to find out the impact of the Covid-19 pandemic on diagnosis and treatment of acute coronary syndromes during March 2020 in Austria. Basically, they tried to account for the collateral damage we all imagine, but no government reports. 

COVID-19 y el daño colateral que nadie contabiliza

During March we observed a significant drop in the number of ACS patients admitted to the emergency rooms. This drop is close to 40% and is even bigger when it comes to Non-STEMI patients.

It came as a surprise to the authors, who had speculated with an increase in the number of cases, according to their experience with other viral infections, natural disasters, or profound financial crisis. We could say Covid-19 is a combination of all three.

The strict health care protocols that undoubtedly helped and keep helping to control this pandemic might have unintentionally affected the attention paid to other diseases. 


Read also: Special Articles on COVID-19.


ACS symptoms such as dyspnea and chest discomfort might easily be mistaken for acute respiratory infections. 

In addition, strict instructions to stay at home and fear of catching the disease might have caused many patients to avoid hospitals despite clearly manifesting symptoms. 

Regardless possible reasons and speculations, the smaller number of patients being treated will eventually translate into increased early and late cardiovascular mortality. This is the unaccounted, and therefore unreported, death toll no government will address.


Read also: Cardiovascular Sequelae Associated with COVID-19.


Compared against similar periods in a pre-pandemic context, and considering  1950 MI mortality rates (times we had nothing to offer, just like the present context, with untreated CAD patients undergoing an ACS at home) we can easily assume there have been 110 unaccounted ACS deaths during March alone for a population of 8.8 million people, such as Austria’s.

The government of Austria has informed 86 deaths due to coronavirus in this same month. However, collateral damage from the virus protocols can be worse yet than the virus itself. 

Original Title: Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage.

Reference: Bernhard Metzler et al. European Heart Journal (2020) 41, 1852–1853. doi:10.1093/eurheartj/ehaa314.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...

Dual-Prep Registry: Atherectomy and IVL for Severe Coronary Calcification

Severe coronary calcification remains one of the most challenging scenarios in percutaneous coronary intervention (PCI). Although rotational or orbital atherectomy and intravascular lithotripsy (IVL)...

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...